XML 82 R71.htm IDEA: XBRL DOCUMENT v3.25.3

Stockholders’ Deficit - Schedule of common stock issuable upon exercise of warrants outstanding (Details)	9 Months Ended
	Sep. 30, 2025 $ / shares shares
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	26,090,232
Number of Warrants Exercised (in shares)	4,312,720
Number of Warrants Cancelled (in shares)	472,500
Number of Warrants Exercisable (in shares)	21,305,012
Adjusted Number of Warrants Exercisable (in shares)	50,150,651
Public Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	7,188
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	7,188
Exercise price (in dollars per share) | $ / shares	$ 4,600
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 4,600
Adjusted Number of Warrants Exercisable (in shares)	7,188
Private Warrants - February 2020
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	341
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	341
Exercise price (in dollars per share) | $ / shares	$ 4,600
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 4,600
Adjusted Number of Warrants Exercisable (in shares)	341
PIPE Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	3,384
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	3,384
Exercise price (in dollars per share) | $ / shares	$ 4,600
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 4,600
Adjusted Number of Warrants Exercisable (in shares)	3,384
2022 July Institutional/Accredited Investor Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	10,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	10,000
Exercise price (in dollars per share) | $ / shares	$ 1,500
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 1,500
Adjusted Number of Warrants Exercisable (in shares)	10,000
Underwriter Warrants - February 2024 offering
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	48,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	22,500
Number of Warrants Exercisable (in shares)	25,500
Exercise price (in dollars per share) | $ / shares	$ 20.00
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 20.00
Adjusted Number of Warrants Exercisable (in shares)	25,500
2024 February Institutional/Accredited Investor Warrants - series A
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	480,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	480,000
Exercise price (in dollars per share) | $ / shares	$ 20.00
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 20.00
Adjusted Number of Warrants Exercisable (in shares)	480,000
2024 February Institutional/Accredited Investor Warrants - series C
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	480,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	450,000
Number of Warrants Exercisable (in shares)	30,000
Exercise price (in dollars per share) | $ / shares	$ 20.00
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 20.00
Adjusted Number of Warrants Exercisable (in shares)	30,000
2024 October Institutional/Accredited Investor Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	2,076,036
Number of Warrants Exercised (in shares)	1,700,351
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	375,685
Exercise price (in dollars per share) | $ / shares	$ 0.74
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 0.1711
Adjusted Number of Warrants Exercisable (in shares)	1,623,501
2024 December Institutional/Accredited Investor Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	277,780
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	277,780
Exercise price (in dollars per share) | $ / shares	$ 1.00
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 1.00
Adjusted Number of Warrants Exercisable (in shares)	277,780
2025 March Institutional/Accredited Investor Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	1,777,750
Number of Warrants Exercised (in shares)	285,028
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	1,492,722
Exercise price (in dollars per share) | $ / shares	$ 0.74
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 0.1711
Adjusted Number of Warrants Exercisable (in shares)	6,483,939
2025 April Institutional/Accredited Investor Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	1,953,537
Number of Warrants Exercised (in shares)	769,546
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	1,183,991
Exercise price (in dollars per share) | $ / shares	$ 0.74
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 0.1711
Adjusted Number of Warrants Exercisable (in shares)	4,980,253
2025 May Institutional/Accredited Investor Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	5,341,879
Number of Warrants Exercised (in shares)	50,000
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	5,291,879
Exercise price (in dollars per share) | $ / shares	$ 0.78
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 0.1711
Adjusted Number of Warrants Exercisable (in shares)	24,102,223
2025 July Institutional/Accredited Investor Pre-funded Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	1,984,940
Number of Warrants Exercised (in shares)	1,507,795
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	477,145
Exercise price (in dollars per share) | $ / shares	$ 0.0001
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 0.0001
Adjusted Number of Warrants Exercisable (in shares)	477,145
2025 September Institutional/Accredited Investor Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	649,393
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	649,393
Exercise price (in dollars per share) | $ / shares	$ 0.1711
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 0.1711
Adjusted Number of Warrants Exercisable (in shares)	649,393
Warrants - May 7, 2025 - 1st Tranche
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	3,000,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	3,000,000
Exercise price (in dollars per share) | $ / shares	$ 1.05
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 1.05
Adjusted Number of Warrants Exercisable (in shares)	3,000,000
Warrants - May 7, 2025 - 2nd Tranche
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	3,000,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	3,000,000
Exercise price (in dollars per share) | $ / shares	$ 1.25
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 1.25
Adjusted Number of Warrants Exercisable (in shares)	3,000,000
Warrants - May 7, 2025 - 3rd Tranche
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	3,000,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	3,000,000
Exercise price (in dollars per share) | $ / shares	$ 1.50
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 1.50
Adjusted Number of Warrants Exercisable (in shares)	3,000,000
Warrants - May 18, 2025 - 1st Tranche
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	666,668
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	666,668
Exercise price (in dollars per share) | $ / shares	$ 1.00
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 1.00
Adjusted Number of Warrants Exercisable (in shares)	666,668
Warrants - May 18, 2025 - 2nd Tranche
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	666,668
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	666,668
Exercise price (in dollars per share) | $ / shares	$ 1.25
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 1.25
Adjusted Number of Warrants Exercisable (in shares)	666,668
Warrants - May 18, 2025 - 3rd Tranche
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	666,668
Number of Warrants Exercised (in shares)	0
Number of Warrants Cancelled (in shares)	0
Number of Warrants Exercisable (in shares)	666,668
Exercise price (in dollars per share) | $ / shares	$ 1.50
Adjusted Exercise Price (In dollars per shares) | $ / shares	$ 1.50
Adjusted Number of Warrants Exercisable (in shares)	666,668

X

- Definition

Class of Warrant Or Right, Adjusted Exercise Price Of Warrants Or Rights

+ References

No definition available.

+ Details

Name:	nvve_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights
Namespace Prefix:	nvve_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Class of Warrant Or Right , Adjusted Number Of Warrants Exercisable

+ References

No definition available.

+ Details

Name:	nvve_ClassOfWarrantOrRightAdjustedNumberOfWarrantsExercisable
Namespace Prefix:	nvve_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Class of Warrant or Right, Exercised

+ References

No definition available.

+ Details

Name:	nvve_ClassOfWarrantOrRightExercised
Namespace Prefix:	nvve_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Class of Warrant or Right, Number Of Warrants Exercisable

+ References

No definition available.

+ Details

Name:	nvve_ClassOfWarrantOrRightNumberOfWarrantsExercisable
Namespace Prefix:	nvve_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number Of Warrants Cancelled

+ References

No definition available.

+ Details

Name:	nvve_NumberOfWarrantsCancelled
Namespace Prefix:	nvve_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvve_StockholdersEquityDetailsScheduleofcommonstockissuableuponexerciseofwarrantsoutstandingLineItems
Namespace Prefix:	nvve_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Number of increase (decrease) in shares of stock classified as other.

+ References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityOtherShares
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_PublicWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_PrivateWarrantsFebruary2020Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_PIPEWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_July2022InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_UnderwriterWarrantsFebruary2024OfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_February2024InstitutionalAccreditedInvestorWarrantsSeriesAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_February2024InstitutionalAccreditedInvestorWarrantsSeriesCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_October2024InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_December2024InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_March2025InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_April2025InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_May2025InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_July2025InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_September2025InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants1stTrancheMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants2ndTrancheMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants3rdTrancheMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants4thTrancheMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants5thTrancheMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=nvve_May2025ConsultingWarrants6thTrancheMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: